Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 245 results found. Search for [ active pharmaceutical ingredients ]

Results 1 to 21 of 245
Aseem Thapliyal
November 27, 2020
An investment of Rs 1 lakh in the share a year ago would have grown to Rs 4.51 lakh today


PB Jayakumar
November 25, 2020
Laurus is one of India's leading manufacturers of active pharmaceutical ingredients (API) for Anti-Retroviral (ARV), Oncology, Cardiovascular, Anti-Diabetics, Anti-Asthma and Gastroenterology medicines, besides pharmaceutical contract manufacturing services


PTI
November 8, 2020
The drug firm has earmarked digital adoption and resilient operations as first of the key priorities for the coming quarters to achieve sustained growth


Professor Himanshu Rai
November 5, 2020
The government can make it mandatory for new Chinese entrants to have a joint venture with an Indian firm as a partner, should they choose to start a business in India, a similar policy is followed by China


BusinessToday.In
October 29, 2020
India Stock Market Highlights Today: Titan, followed by L&T, ONGC, Tech Mahindra, Bajaj Auto, HUL and Nestle India were among the top laggards in the Sensex pack. On the other hand, Axis Bank, Asian Paints, UltraTech Cement and HCL Tech were among the gainers


Reuters
October 26, 2020
On a month-on-month and seasonally adjusted basis, industrial production increased 10.1% in September, data from the Singapore Economic Development Board showed


BusinessToday.In
October 9, 2020
The trade deficit between India and China from April-August stands at $12.6 billion as compared to $22.6 billion in April-August period of FY20. In FY19, this was $23.5 billion and $26.33 billion in FY18


BusinessToday.In
October 7, 2020
Shares of Solara Active Pharma Sciences have soared 8% in the last week in comparison to the S&P BSE Sensex that increased 4% in the same period


Aseem Thapliyal
October 7, 2020
An investment of Rs 1 lakh in this stock on April 7 this year would have turned to Rs 6.13 lakh today


Aseem Thapliyal
September 17, 2020
An investment of Rs 1 lakh in the mid cap share on March 19 would have grown to Rs 8.82 lakh on August 25


PTI
September 8, 2020
Speaking at the 14th Annual BioPharma and Healthcare Summit, he said India is now gearing up for innovation in its pharmaceutical ecosystem focusing on speedy and scaled up delivery of new vaccines and personalised medicines


PB Jayakumar
New Delhi, September 1, 2020
GMM Pfaudler has made strategic acquisitions, diversified its product basket and invested in new capacities with an eye on long-term growth


PTI
August 25, 2020
In India, the government and the private sector have worked together to ensure the integrity of medical supply chains, and essential medicines from India have continued to reach the United States and some 150 partner countries, Sandhu wrote


PTI
August 24, 2020
The pharma companies cumulatively saw their pre-tax margins rising by 306 basis points (bps) on an annualised basis and 551 bps sequentially in the first quarter due to better prices and lower expenses both due to the lockdowns


Aseem Thapliyal
August 21, 2020
An investment of Rs 1 lakh five months ago in the pharma share would have grown to Rs 7.39 lakh today


BusinessToday.In
August 19, 2020
Jairam Ramesh says India depends on China for most of its active pharmaceutical ingredients, and during coronavirus-induced lockdown in May and June, API prices shot up steeply, exposing India's vulnerabilities


BusinessToday.In
August 8, 2020
China's imports from India have gone up 6.7 per cent since January this year to $11.09 billion. As a result, total trade with India has registered a slightly lower 18.6 per cent drop since the beginning of 2020


PB Jayakumar
August 6, 2020
Though margins remain healthy, pricing pressures for the US base generics business, lack of limited competition products and manufacturing quality issues will continue to trouble them, said ICRA


BusinessToday.In
August 3, 2020
Products from around 20 sectors that have a manufacturing advantage and can attract investments are being considered for import restrictions including furniture, leather, footwear, agro-chemicals, and air-conditioners


BusinessToday.In
August 1, 2020
Currently, India imports 68 per cent APIs and more than 90 per cent antibiotics from China. the country's pharmaceutical industry is the world's third-largest in terms of volume


PAGES 1 OF 13  12345